We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · October 15, 2019

Detecting Anti-Cardiolipin and Anti-β2-Glycoprotein I IgM Antibodies in the Antiphospholipid Syndrome

Journal of Thrombosis and Haemostasis (JTH)


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Thrombosis and Haemostasis (JTH)
The (Non-)Sense of Detecting Anti-Cardiolipin and Anti-β2glycoprotein I IgM Antibodies in the Antiphospholipid Syndrome
J. Thromb. Haemost. 2019 Sep 13;[EPub Ahead of Print], W Chayoua, H Kelchtermans, JC Gris, GW Moore, J Musiał, D Wahl, PG de Groot, B de Laat, KMJ Devreese

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading